This dual-modality strategy leverages the metabolic benefits of GLP-1 receptor agonists with the targeted fat-reduction effects of body contouring devices, delivering transformative results without surgery
Originally used to treat diabetes, GLP-1s have become an attractive option for those looking to suppress hunger and shed pounds fast
However, they require longer operative times and careful surgical planning to ensure patient safety
Semaglutide (sold under the brand names Ozempic and Wegovy) is part of this group, while tirzepatide (brand names: Mounjaro and Zepbound) targets both GLP-1 and another hormone, GIP
Understanding the Post-GLP-1 Patient Journey Semaglutide weight loss delivers rapid, often dramatic results
Nooms GLP-1 Companion provides continued coaching, community support, and psychology-based tools designed to help you keep the weight off even after medication ends